Results 41 to 50 of about 261,105 (346)

Pre-Clinical Investigation of Liquid Paclitaxel for Local Drug Delivery: A Pilot Study

Pharmaceuticals, 2020
The purpose of this pilot study was to investigate the feasibility of a perfusion catheter to deliver liquid paclitaxel into arterial segments. A clinically relevant rabbit ilio-femoral injury model was utilized to determine the impact of liquid ...
Claire V. Cawthon, Kathryn Cooper, Clifton Huett, Alyssa Lloret, Estefanny Villar-Matamoros, Lauren Stokes, Uwe Christians, Michele Schuler, Saami K. Yazdani   +8 more
doaj   +1 more source

Glycyrrhizic Acid Prevents Paclitaxel-Induced Neuropathy via Inhibition of OATP-Mediated Neuronal Uptake

Cells, 2023
Peripheral neuropathy is a common side effect of cancer treatment with paclitaxel. The mechanisms by which paclitaxel is transported into neurons, which are essential for preventing neuropathy, are not well understood. We studied the uptake mechanisms of
Ines Klein, Jörg Isensee, Martin H. J. Wiesen, Thomas Imhof, Meike K. Wassermann, Carsten Müller, Tim Hucho, Manuel Koch, Helmar C. Lehmann   +8 more
doaj   +1 more source

Synthesis of Paclitaxel Loaded on Nanoparticles of Archaeosomes and Investigation of Its Anti-cancer Properties

Asian Pacific Journal of Cancer Biology, 2017
Objective: In this study, the effect of archaeosomal paclitaxel drug on breast cancer MDA-MB231 cell lines was evaluated. Material and method: The experiments were conducted to assess the cytotoxicity of paclitaxel in free form and compare it with ...
Maral Mazloumi Tabrizi, Sepideh Jafarzadeh Rastin, Nahid Kabiri, Azim Akbarzadeh Khiyavi   +3 more
doaj   +1 more source

Combination of SAHA and Paclitaxel Induce Apoptosis of Human Cervical Cancer HeLa Cells

Zhongliu Fangzhi Yanjiu, 2018
Objective To investigate the inhibition effect of paclitaxel combined with SAHA on the proliferation of human cervical cancer HeLa cells in vitro and related mechanism.
ZHANG Lei, LIU Hao, JIN Ping, ZHANG Ke, WANG Xiaomei, ZHAO Yingying   +5 more
doaj   +1 more source

The battle of “nano” paclitaxel

Advanced Drug Delivery Reviews, 2017
Paclitaxel (PTX) is one of the three most widely used chemotherapeutic agents, together with doxorubicin and cisplatin, and is first or second line treatment for several types of cancers. In 2000, Taxol, the conventional formulation of PTX, became the best-selling cancer drug of all time with annual sales of 1.6 billion.
Alexandros Marios Sofias, Alexandros Marios Sofias, Michael Dunne, Gert Storm, Christine Allen   +4 more
openaire   +3 more sources

Safety of nab-paclitaxel following an allergic reaction to paclitaxel: A single institution retrospective study

Gynecologic Oncology Reports
The goal of this study was to assess the safety of nab-paclitaxel in patients with ovarian cancer or endometrial cancer who had an allergic reaction to paclitaxel.
Swapna Kochuveettil, Roberto Angeli Morales, Alicja Kaminska, Gerardo Colon-Otero   +3 more
doaj   +1 more source

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.

Journal of Clinical Oncology, 2019
PURPOSE The phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is frequently activated in triple-negative breast cancer (TNBC). The AKT inhibitor capivasertib has shown preclinical activity in TNBC models, and drug sensitivity has been associated
P. Schmid, J. Abraham, S. Chan, D. Wheatley, A. Brunt, G. Nemsadze, R. Baird, Yeon-Hee Park, P. Hall, T. Perren, R. Stein, L. Mangel, J. Ferrero, M. Phillips, J. Conibear, J. Cortés, A. Foxley, E. D. de Bruin, R. McEwen, Daniel B. Stetson, B. Dougherty, S. Sarker, Aaron Prendergast, Max McLaughlin-Callan, M. Burgess, C. Lawrence, H. Cartwright, K. Mousa, N. Turner   +28 more
semanticscholar   +1 more source

Paclitaxel-Induced Endothelial Dysfunction in Living Rats Is Prevented by Nicorandil via Reduction of Oxidative Stress

Journal of Pharmacological Sciences, 2012
Paclitaxel-eluting stents dramatically reduce rates of in-stent restenosis; however, paclitaxel is known to lead to endothelial dysfunction. Protective effects of nicorandil on paclitaxel-induced endothelial dysfunction by examining flow-mediated ...
Ken-ichi Serizawa, Kenji Yogo, Ken Aizawa, Yoshihito Tashiro, Yoko Takahari, Kaori Sekine, Toshihiko Suzuki, Nobuhiko Ishizuka, Hideyuki Ishida   +8 more
doaj   +1 more source

Paclitaxel, Carboplatin, and Trastuzumab [PDF]

Hospital Pharmacy, 2014
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.
Dominic A. Solimando, J. Waddell, Jennifer Lee   +2 more
openaire   +3 more sources

Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up: A Phase 1b Clinical Trial

JAMA Oncology, 2019
Importance The humanized monoclonal antibody atezolizumab targets programmed death-ligand 1 and has demonstrated durable single-agent activity in a subset of metastatic triple-negative breast cancers.
S. Adams, J. Diamond, E. Hamilton, P. Pohlmann, S. Tolaney, Ching-Wei Chang, Wei Zhang, K. Iizuka, P. Foster, L. Molinero, R. Funke, J. Powderly   +11 more
semanticscholar   +1 more source